Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway

Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363:515–521. 10.1038/363515a0

[2]

Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 72:791–800. 10.1016/0092-8674(93)90406-g

[3]

Bianchi AB, Hara T, Ramesh V, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet 1994; 6:185–192. 10.1038/ng0294-185

[4]

Cooper J, Giancotti FG . Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett 2014; 588:2743–2752. 10.1016/j.febslet.2014.04.001

[5]

Schroeder RD, Angelo LS, Kurzrock R . NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget 2014; 5:67–77. 10.18632/oncotarget.1557

[6]

Role of Merlin/NF2 inactivation in tumor biology

A M Petrilli, C Fernández-Valle

Oncogene 2015 10.1038/onc.2015.125

[7]

Fehon RG, McClatchey AI, Bretscher A . Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 2010; 11:276–287. 10.1038/nrm2866

[8]

Pan D . The hippo signaling pathway in development and cancer. Dev Cell 2010; 19:491–505. 10.1016/j.devcel.2010.09.011

[9]

Yu FX, Guan KL . The Hippo pathway: regulators and regulations. Genes Dev 2013; 27:355–371. 10.1101/gad.210773.112

[10]

Hamaratoglu F, Willecke M, Kango-Singh M, et al. The tumour-suppressor genes NF2/Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 2006; 8:27–36. 10.1038/ncb1339

[11]

Harvey K, Tapon N . The Salvador-Warts-Hippo pathway – an emerging tumour-suppressor network. Nat Rev Cancer 2007; 7:182–191. 10.1038/nrc2070

[12]

Hippo signaling: growth control and beyond

Georg Halder, Randy L. Johnson

Development 2011 10.1242/dev.045500

[13]

Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2

Feng Yin, Jianzhong Yu, Yonggang Zheng et al.

Cell 2013 10.1016/j.cell.2013.08.025

[14]

The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP

Jianbin Huang, Shian Wu, Jose Barrera et al.

Cell 2005 10.1016/j.cell.2005.06.007

[15]

Pan D . Hippo signaling in organ size control. Genes Dev 2007; 21:886–897. 10.1101/gad.1536007

[16]

Li W, You L, Cooper J, et al. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 2010; 140:477–490. 10.1016/j.cell.2010.01.029

[17]

Pearson MA, Reczek D, Bretscher A, Karplus PA . Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000; 101:259–270. 10.1016/s0092-8674(00)80836-3

[18]

Li Q, Nance MR, Kulikauskas R, et al. Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain. J Mol Biol 2007; 365:1446–1459. 10.1016/j.jmb.2006.10.075

[19]

Gonzalez-Agosti C, Wiederhold T, Herndon ME, Gusella J, Ramesh V . Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF. J Biol Chem 1999; 274:34438–34442. 10.1074/jbc.274.48.34438

[20]

Sher I, Hanemann CO, Karplus PA, Bretscher A . The tumor suppressor merlin controls growth in its open state, and phosphorylation converts it to a less-active more-closed state. Dev Cell 2012; 22:703–705. 10.1016/j.devcel.2012.03.008

[21]

Shaw RJ, Paez JG, Curto M, et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 2001; 1:63–72. 10.1016/s1534-5807(01)00009-0

[22]

Xiao GH, Beeser A, Chernoff J, Testa JR . p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem 2002; 277:883–886. 10.1074/jbc.c100553200

[23]

Kissil JL, Wilker EW, Johnson KC, Eckman MS, Yaffe MB, Jacks T . Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Mol Cell 2003; 12:841–849. 10.1016/s1097-2765(03)00382-4

[24]

Surace EI, Haipek CA, Gutmann DH . Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene 2004; 23:580–587. 10.1038/sj.onc.1207142

[25]

Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K . Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Oncogene 2004; 23:8447–8454. 10.1038/sj.onc.1207794

[26]

Kissil JL, Johnson KC, Eckman MS, Jacks T . Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 2002; 277:10394–10399. 10.1074/jbc.m200083200

[27]

Ali Khajeh J, Ju JH, Atchiba M, et al. Molecular conformation of the full-length tumor suppressor NF2/Merlin — a small-angle neutron scattering study. J Mol Biol 2014; 426:2755–2768. 10.1016/j.jmb.2014.05.011

[28]

NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions

Dominique Lallemand, Marcello Curto, Ichiko Saotome et al.

Genes & Development 2003 10.1101/gad.1054603

[29]

Gladden AB, Hebert AM, Schneeberger EE, McClatchey AI . The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell 2010; 19:727–739. 10.1016/j.devcel.2010.10.008

[30]

Yi C, Troutman S, Fera D, et al. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 2011; 19:527–540. 10.1016/j.ccr.2011.02.017

[31]

McLaughlin ME, Kruger GM, Slocum KL, et al. The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion. Proc Natl Acad Sci USA 2007; 104:3261–3266. 10.1073/pnas.0700044104

[32]

Hirate Y, Hirahara S, Inoue K, et al. Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol 2013; 23:1181–1194. 10.1016/j.cub.2013.05.014

[33]

Contact-dependent inhibition of EGFR signaling by Nf2/Merlin

Marcello Curto, Banumathi K. Cole, Dominique Lallemand et al.

The Journal of cell biology 2007 10.1083/jcb.200703010

[34]

Benhamouche S, Curto M, Saotome I, et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev 2010; 24:1718–1730. 10.1101/gad.1938710

[35]

Moleirinho S, Guerrant W, Kissil JL . The Angiomotins – from discovery to function. FEBS Lett 2014; 588:2693–2703. 10.1016/j.febslet.2014.02.006

[36]

Nguyen R, Reczek D, Bretscher A . Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J Biol Chem 2001; 276:7621–7629. 10.1074/jbc.m006708200

[37]

Bretscher A, Edwards K, Fehon RG . ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002; 3:586–599. 10.1038/nrm882

[38]

Reczek D, Bretscher A . The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J Biol Chem 1998; 273:18452–18458. 10.1074/jbc.273.29.18452

[39]

Ahronowitz I, Xin W, Kiely R, Sims K, MacCollin M, Nunes FP . Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat 2007; 28:1–12. 10.1002/humu.20393

[40]

Shimizu T, Seto A, Maita N, et al. Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain. J Biol Chem 2002; 277:10332–10336. 10.1074/jbc.m109979200

[41]

LaJeunesse DR, McCartney BM, Fehon RG . Structural analysis of Drosophila merlin reveals functional domains important for growth control and subcellular localization. J Cell Biol 1998; 141:1589–1599. 10.1083/jcb.141.7.1589

[42]

Zhao B, Li L, Lu Q, et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25:51–63. 10.1101/gad.2000111

[43]

Aragona M, Panciera T, Manfrin A, et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 2013; 154:1047–1059. 10.1016/j.cell.2013.07.042

[44]

Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction. Nature 2011; 474:179–183. 10.1038/nature10137

[45]

Hippo pathway regulation by cell morphology and stress fibers

Ken-Ichi Wada, Kazuyoshi Itoga, Teruo Okano et al.

Development 2011 10.1242/dev.070987

[46]

Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL . Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 2012; 26:54–68. 10.1101/gad.173435.111

[47]

Sansores-Garcia L, Bossuyt W, Wada K, et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J 2011; 30:2325–2335. 10.1038/emboj.2011.157

[48]

Mana-Capelli S, Paramasivam M, Dutta S, McCollum D . Angiomotins link F-actin architecture to Hippo pathway signaling. Mol Biol Cell 2014; 25:1676–1685. 10.1091/mbc.e13-11-0701

[49]

Leung CY, Zernicka-Goetz M . Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms. Nat Commun 2013; 4:2251. 10.1038/ncomms3251

[50]

Chan SW, Lim CJ, Guo F, Tan I, Leung T, Hong W . Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J Biol Chem 2013; 288:37296–37307. 10.1074/jbc.m113.527598

Showing 50 of 62 references

Cited By

128

Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression

Xiaomin Cai, Kuei-Chun Wang · 2021

Frontiers in Cell and Developmental...

Control of cellular responses to mechanical cues through YAP/TAZ regulation

Ishani Dasgupta, Dannel McCollum · 2019

Journal of Biological Chemistry

Metrics

128

Citations

62

References

Details

Published: Jun 05, 2015
Vol/Issue: 25(7)
Pages: 801-817
License: View

Authors

Department of Cell Biology and Liaoning Laboratory of Cancer Genetics and Epigenetics; Dalian Medical University; China

Department of Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Cite This Article

Youjun Li, FengZhi Li, Siew Wee Chan, et al. (2015). Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. Cell Research, 25(7), 801-817. https://doi.org/10.1038/cr.2015.69

Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway

You May Also Like